April 28 (Reuters) - Adicet Bio Inc ACET.O:
ADICET BIO ANNOUNCES ORAL PRESENTATION HIGHLIGHTING PRECLINICAL ADI-270 DATA AT THE AMERICAN SOCIETY OF GENE AND CELL THERAPY (ASGCT) 28TH ANNUAL MEETING
Source text: ID:nBw5P7c7ja
Further company coverage: ACET.O
(Reuters.Briefs@thomsonreuters.com)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.